Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial

From The Hill

Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.

Source Author
Author: Source Author

Written by

Rob Taub

in

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts